Detalles de la búsqueda
1.
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Haematologica
; 107(11): 2650-2660, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35443560
2.
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
J Thromb Haemost
; 21(2): 269-275, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36700507
3.
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
J Virol
; 83(10): 5192-203, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19279103
4.
Development of an In Vitro Biopotency Assay for an AAV8 Hemophilia B Gene Therapy Vector Suitable for Clinical Product Release.
Mol Ther Methods Clin Dev
; 17: 581-588, 2020 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32280725
5.
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays.
Hum Gene Ther Methods
; 30(2): 35-43, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30734588
6.
MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses.
PLoS One
; 9(2): e88340, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24523886
7.
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
Vaccine
; 30(31): 4625-31, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22580355
8.
Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever.
PLoS One
; 6(9): e24505, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21931732
9.
Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity.
PLoS One
; 6(1): e16247, 2011 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21283631
10.
Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.
Vaccine
; 29(24): 4132-41, 2011 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-21477673
11.
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.
PLoS One
; 5(8): e12217, 2010 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20808939
Resultados
1 -
11
de 11
1
Próxima >
>>